A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009126/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to investigate the long-term safety and any side effects of
baricitinib in participants who have completed a previous baricitinib rheumatoid arthritis
study.
The study provides 7 years of additional treatment with baricitinib.
提供机构：
Vivli
创建时间：
2023-07-31
